Johannes Fruehauf, MD, PhD
Co-Founder and General Partner, BioInnovation Capital
Dr. Fruehauf is the Co-Founder and General Partner of BioInnovation Capital. He is also a Founder and current President and Executive Director of LabCentral, a launchpad for high-potential biotech startups. Prior to LabCentral, he founded Cambridge Biolabs, a contract research facility serving startup and virtual companies in Kendall Square. Dr. Fruehauf is also a Co-Founder of ViThera Pharmaceuticals, Deltix and Cequent Pharmaceuticals, and an advisor or board member to numerous life sciences companies and non-profits.